Literature DB >> 6418300

Electroconvulsive therapy: results in depressive illness from the Leicestershire trial.

S Brandon, P Cowley, C McDonald, P Neville, R Palmer, S Wellstood-Eason.   

Abstract

Electroconvulsive therapy was investigated in a double blind trial. Altogether 186 clinically selected patients were referred to the trial, but 48 of these did not participate. According to the present state examination, 95 of the remaining 138 patients fell into one of the classes of major depression. Patients were randomly allocated to a course of real or simulated electroconvulsive therapy. Treatment was given twice a week with a maximum of eight treatments. On the Hamilton depressive rating scale the improvement in the group given real treatment was significantly greater than that in the group given simulated treatment both at two weeks (p = 0.014) and at four weeks (p = 0.0001). At follow up at 12 and 28 weeks there was no difference between the treatment groups. At the end of the four week trial consultants, who were blind to the allocation of treatment, rated the patients who had received real treatment as having made a significantly greater improvement than the patients who had received simulated treatment (p less than 0.00005). Further analysis showed that electroconvulsive therapy was effective in depression associated with delusions and in depression associated with retardation.

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Year:  1984        PMID: 6418300      PMCID: PMC1444141          DOI: 10.1136/bmj.288.6410.22

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

1.  THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE.

Authors:  M W CARNEY; M ROTH; R F GARSIDE
Journal:  Br J Psychiatry       Date:  1965-08       Impact factor: 9.319

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Insulin treatment of schizophrenia; a controlled study.

Authors:  B ACKNER; A HARRIS; A J OLDHAM
Journal:  Lancet       Date:  1957-03-23       Impact factor: 79.321

4.  A comprehensive psychopathological rating scale.

Authors:  M Asberg; S A Montgomery; C Perris; D Schalling; G Sedvall
Journal:  Acta Psychiatr Scand Suppl       Date:  1978

5.  A controlled comparison of simulated and real ECT.

Authors:  J Lambourn; D Gill
Journal:  Br J Psychiatry       Date:  1978-12       Impact factor: 9.319

Review 6.  Measurement of feelings using visual analogue scales.

Authors:  R C Aitken
Journal:  Proc R Soc Med       Date:  1969-10

7.  The Northwick Park electroconvulsive therapy trial.

Authors:  E C Johnstone; J F Deakin; P Lawler; C D Frith; M Stevens; K McPherson; T J Crow
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

8.  Double-blind controlled trail of electroconvulsive therapy (E.C.T.) and simulated E.C.T. in depressive illness.

Authors:  C P Freeman; J V Basson; A Crighton
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

9.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

10.  Electric convulsion therapy in depression: a double-blind controlled trial.

Authors:  E D West
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31
  10 in total
  9 in total

Review 1.  The electroconvulsive therapy controversy: evidence and ethics.

Authors:  Andrew D Reisner
Journal:  Neuropsychol Rev       Date:  2003-12       Impact factor: 7.444

2.  Relief of expressed suicidal intent by ECT: a consortium for research in ECT study.

Authors:  Charles H Kellner; Max Fink; Rebecca Knapp; Georgios Petrides; Mustafa Husain; Teresa Rummans; Martina Mueller; Hilary Bernstein; Keith Rasmussen; Kevin O'connor; Glenn Smith; A John Rush; Melanie Biggs; Shawn McClintock; Samuel Bailine; Chitra Malur
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

3.  Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials.

Authors:  Kaitlin R McManus; Maria I Lapid; Brent P Forester; Martina Mueller; Adriana P Hermida; Louis Nykamp; David G Harper; Stephen J Seiner; Sohag Sanghani; Regan Patrick; Melanie T Gentry; Simon Kung; Janette C Leal; Emily K Johnson; Georgios Petrides
Journal:  J ECT       Date:  2022-03-01       Impact factor: 3.692

4.  5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice.

Authors:  G M Goodwin; A R Green; P Johnson
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

Review 5.  Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.

Authors:  Nancy A Payne; Joan Prudic
Journal:  J Psychiatr Pract       Date:  2009-09       Impact factor: 1.325

6.  Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment.

Authors:  A R Green; J A Mountford
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy.

Authors:  R H Segman; B Shapira; M Gorfine; B Lerer
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

Review 8.  A critique of narrative reviews of the evidence-base for ECT in depression.

Authors:  C F Meechan; K R Laws; A H Young; D M McLoughlin; S Jauhar
Journal:  Epidemiol Psychiatr Sci       Date:  2022-01-27       Impact factor: 6.892

9.  A response to yet another defence of ECT in the absence of robust efficacy and safety evidence.

Authors:  John Read
Journal:  Epidemiol Psychiatr Sci       Date:  2022-02-15       Impact factor: 6.892

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.